Corcept Therapeutics Incorporated
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2000 | 92.3% | 92.3% | — |
| FY2001 | 98.9% | 98.9% | — |
| FY2002 | 84.3% | 84.3% | — |
| FY2003 | 31.2% | 31.2% | — |
| FY2004 | -33.8% | -33.8% | — |
| FY2005 | -75.6% | -75.6% | — |
| FY2006 | -391.1% | -391.1% | — |
| FY2007 | -78.5% | -78.5% | — |
| FY2008 | -118.7% | -118.7% | — |
| FY2009 | -91.3% | -91.3% | — |
| FY2010 | -122.2% | -122.2% | -103.4% |
| FY2011 | -93.0% | -93.0% | -81.2% |
| FY2012 | -61.6% | -41.9% | -38.4% |
| FY2013 | -218.9% | -91.4% | -72.9% |
| FY2014 | 926.3% | -148.9% | -90.6% |
| FY2015 | -34.6% | -20.7% | -12.3% |
| FY2016 | 19.7% | 19.7% | 11.8% |
| FY2017 | 67.6% | 67.6% | 58.5% |
| FY2018 | 27.3% | 27.3% | 24.2% |
| FY2019 | 25.4% | 25.4% | 22.8% |
| FY2020 | 20.3% | 20.3% | 18.5% |
| FY2021 | 29.9% | 29.9% | 26.6% |
| FY2022 | 20.2% | 20.2% | 17.4% |
| FY2023 | 20.9% | 20.9% | 17.1% |
| FY2024 | 20.8% | 20.8% | 16.8% |
| FY2025 | 15.4% | 15.4% | 11.9% |